Literature DB >> 31916300

Novel balloon catheter-based endobiliary radiofrequency ablation system: Ex-vivo experimental study.

Tadahisa Inoue1, Kiyoaki Ito1, Masashi Yoneda1.   

Abstract

BACKGROUND: Endobiliary radiofrequency ablation (RFA) is a promising treatment option for malignant biliary obstruction, but conventional catheter RFA (Conventional-RFA) has several limitations. We examined the feasibility of a novel approach to balloon-based RFA (Balloon-RFA) with an automatic temperature control system in freshly resected pig livers.
METHODS: Balloon-RFA application was performed in a step-by-step manner at target temperatures of 50°C, 60°C, and 70°C. The temperatures were maintained for 60 s. As a control, Conventional-RFA was performed at 7 W of power for 90 s, 7 W 120 s, 10 W 90 s, and 10 W 120 s. The ablation areas were measured and compared between Balloon-RFA and Conventional-RFA.
RESULTS: The maximum ablation depths in Balloon-RFA were 1.86 ± 0.53, 2.29 ± 0.31, and 3.19 ± 0.47 mm at target temperatures of 50, 60, and 70°C, respectively. The maximum ablation depths in Conventional-RFA were 2.81 ± 0.46, 4.09 ± 0.45, 3.41 ± 0.58, and 4.27 ± 0.29 mm at 7 W 90 s, 7 W 120 s, 10 W 90 s, and 10 W 120 s, respectively. Differences between the minimum and maximum depths were significantly smaller in Balloon-RFA (0.73 ± 0.31 mm) than in Conventional-RFA (2.00 ± 0.62 mm; P < 0.001). Excessive ablation occurred only in Conventional-RFA (0% vs. 67%; P = 0.005).
CONCLUSIONS: The novel balloon-based RFA system allows ablation to be finely tuned in order to successfully obtain consistent ablation depths and avoid excessive ablation.
© 2020 Japan Gastroenterological Endoscopy Society.

Entities:  

Keywords:  balloon catheter; malignant biliary obstruction; radiofrequency ablation

Mesh:

Year:  2020        PMID: 31916300     DOI: 10.1111/den.13622

Source DB:  PubMed          Journal:  Dig Endosc        ISSN: 0915-5635            Impact factor:   7.559


  4 in total

1.  Endobiliary Radiofrequency Ablation Combined with Gemcitabine and Cisplatin in Patients with Unresectable Extrahepatic Cholangiocarcinoma.

Authors:  Tadahisa Inoue; Itaru Naitoh; Rena Kitano; Mayu Ibusuki; Yuji Kobayashi; Yoshio Sumida; Yukiomi Nakade; Kiyoaki Ito; Masashi Yoneda
Journal:  Curr Oncol       Date:  2022-03-23       Impact factor: 3.109

2.  Feasibility of balloon-based endobiliary radiofrequency ablation under cholangioscopy guidance in a swine model.

Authors:  Tadahisa Inoue; Hiromu Kutsumi; Mayu Ibusuki; Masashi Yoneda
Journal:  Sci Rep       Date:  2021-07-09       Impact factor: 4.379

Review 3.  Endoscopic Management of Malignant Biliary Stricture.

Authors:  Robert Dorrell; Swati Pawa; Rishi Pawa
Journal:  Diagnostics (Basel)       Date:  2020-06-10

4.  Endoscopic Ultrasound-Guided Antegrade Radiofrequency Ablation and Metal Stenting With Hepaticoenterostomy for Malignant Biliary Obstruction: A Prospective Preliminary Study.

Authors:  Tadahisa Inoue; Mayu Ibusuki; Rena Kitano; Yuji Kobayashi; Tomohiko Ohashi; Yoshio Sumida; Yukiomi Nakade; Kiyoaki Ito; Masashi Yoneda
Journal:  Clin Transl Gastroenterol       Date:  2020-10       Impact factor: 4.396

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.